NASDAQ
No price data available for this timeframe.
Harrow Health, Inc. (HROW) has a price/sales ratio of 6.61x as of Friday, May 22, 2026. This represents a 59.76% increase compared to its 12-month average of 4.14x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.